The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 341:755-757 September 2, 1999 Number 10
NextNext

Clinical Implications of the Hemochromatosis Gene

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Olynyk, J. K.
-Related Article
 by Pietrangelo, A.
-PubMed Citation
Hereditary hemochromatosis is the most common genetic disorder in whites. The prevalence of this condition (i.e., of homozygosity for the faulty gene) in the white population is approximately 1 in 250.1,2 The localization of the gene to the short arm of chromosome 6 (6p) by means of linkage studies confirmed the genetic nature of the disorder, but the actual gene remained elusive until the advent of positional cloning. The faulty hemochromatosis gene (HFE ) was discovered in 1996,3 and since then multiple reports have confirmed that a point mutation in HFE (the substitution of tyrosine for cysteine at position . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.